Yongin-si, South Korea

Mi Jung Lee


 

 

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Yongin-si, KR (2018 - 2021)
  • Gyeonggi-do, KR (2015 - 2024)

Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Mi Jung Lee: Innovator in Antibody Technology

Introduction

Mi Jung Lee is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of antibody libraries and screening methods. With a total of seven patents to her name, her work has the potential to impact various medical applications.

Latest Patents

One of her latest patents is focused on an antibody library and an antibody screening method using the same. This invention relates to a novel antibody library that exhibits high thermodynamic stability, allowing for high soluble expression and reversible folding. The antibody includes a variety of rationally controlled CDRs, which enable high specificity and affinity to all antigens. This innovation can be advantageous for selecting suitable candidate antibodies against target antigens.

Another significant patent involves a 1,2-naphthoquinone-based derivative and a method of preparing the same. This patent discloses a compound that has effects for the treatment or prevention of metabolic syndromes. The invention includes a pharmaceutical composition that can be beneficial in addressing these health issues.

Career Highlights

Throughout her career, Mi Jung Lee has worked with notable companies such as Yungjin Pharm Co., Ltd. and LG Display Co., Ltd. Her experience in these organizations has contributed to her expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Mi Jung Lee has collaborated with several professionals in her field, including Whee Seong Lee and Bo Jung Kim. These collaborations have likely enhanced her research and development efforts, leading to innovative solutions in antibody technology.

Conclusion

Mi Jung Lee is a distinguished inventor whose work in antibody technology has the potential to revolutionize medical treatments. Her patents reflect her commitment to advancing biotechnology and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…